Vertex Pharmaceuticals Inc (VRTX)
440.64
+3.15
(+0.72%)
USD |
NASDAQ |
May 16, 16:00
442.00
+1.36
(+0.31%)
Pre-Market: 08:08
Vertex Pharmaceuticals Free Cash Flow (Quarterly): 1.058B for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.058B |
| December 31, 2023 | 118.50M |
| September 30, 2023 | 1.228B |
| June 30, 2023 | 1.075B |
| March 31, 2023 | 857.80M |
| December 31, 2022 | 1.045B |
| September 30, 2022 | 901.30M |
| June 30, 2022 | 1.086B |
| March 31, 2022 | 892.60M |
| December 31, 2021 | 933.20M |
| September 30, 2021 | 874.80M |
| June 30, 2021 | -249.60M |
| March 31, 2021 | 850.10M |
| December 31, 2020 | 443.84M |
| September 30, 2020 | 732.95M |
| June 30, 2020 | 1.021B |
| March 31, 2020 | 796.25M |
| December 31, 2019 | 429.27M |
| September 30, 2019 | 310.50M |
| June 30, 2019 | 447.39M |
| March 31, 2019 | 306.74M |
| December 31, 2018 | 298.93M |
| September 30, 2018 | 360.44M |
| June 30, 2018 | 292.09M |
| March 31, 2018 | 223.38M |
| Date | Value |
|---|---|
| December 31, 2017 | 184.53M |
| September 30, 2017 | -17.87M |
| June 30, 2017 | 164.28M |
| March 31, 2017 | 254.59M |
| December 31, 2016 | 129.94M |
| September 30, 2016 | 51.77M |
| June 30, 2016 | 24.94M |
| March 31, 2016 | -27.11M |
| December 31, 2015 | 16.62M |
| September 30, 2015 | -70.87M |
| June 30, 2015 | -123.69M |
| March 31, 2015 | -232.79M |
| December 31, 2014 | -196.46M |
| September 30, 2014 | -96.94M |
| June 30, 2014 | -139.62M |
| March 31, 2014 | -191.29M |
| December 31, 2013 | 5.288M |
| September 30, 2013 | -32.23M |
| June 30, 2013 | -2.728M |
| March 31, 2013 | -82.38M |
| December 31, 2012 | 12.51M |
| September 30, 2012 | 84.56M |
| June 30, 2012 | 102.86M |
| March 31, 2012 | -3.239M |
| December 31, 2011 | 554.33M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-249.60M
Minimum
Jun 2021
1.228B
Maximum
Sep 2023
742.58M
Average
866.30M
Median
Free Cash Flow (Quarterly) Benchmarks
| Amgen Inc | 459.00M |
| Eli Lilly and Co | 83.20M |
| Regeneron Pharmaceuticals Inc | 1.351B |
| Alpine Immune Sciences Inc | -27.71M |
| Editas Medicine Inc | -51.74M |